Status:
UNKNOWN
Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Sarcoma of Pelvis
Eligibility:
All Genders
16+ years
Phase:
PHASE2
Brief Summary
This study looks at isolated pelvic perfusion and limbs' girdle with 1 mg tumor necrosis factor alpha (TNFa) in the treatment of locally advanced sarcoma of the pelvis and limbs' girdle.
Eligibility Criteria
Inclusion
- Soft tissue or bone sarcomas locally advanced of the pelvis or limbs' girdle
Exclusion
- Resectable tumor without mutilation
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00181025
Start Date
May 1 2004
Last Update
June 12 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Gustave-Roussy
Villejuif, France, 94800